Parvovirus B19 in human disease

Annual Review of Medicine

Volumn 48, Issue , 1997, Pages 59-67

  Brown, K E ^a   Young, N S ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Erythema infectiosum; Hematological disease; Human parvovirus B19; Infectious arthritis; Pathogenesis; Pregnancy complications

Indexed keywords

ANEMIA; APLASTIC ANEMIA; ERYTHEMA INFECTIOSUM; FETUS HYDROPS; HUMAN; IMMUNE DEFICIENCY; INTRAUTERINE INFECTION; PARVOVIRUS; PATHOPHYSIOLOGY; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; PURE RED CELL ANEMIA; REVIEW; VIRUS INFECTION;

ADULT; CHILD; ERYTHEMA INFECTIOSUM; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; OPPORTUNISTIC INFECTIONS; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; PREGNANCY; PROGNOSIS;

EID: 0031048148     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.med.48.1.59     Document Type: Review

References (30)

1. Siegl G, Bates RC, Berns KI, et al. 1985. Characteristics and taxonomy of Parvoviridae. Intervirology 23:61-73
2. Ozawa K, Ayub J, Hao YS, et al. 1987. Novel transcription map for the B19 (human) pathogenic parvovirus. J. Virol. 61: 2395-406
3. Kajigaya S, Fujii H, Field A, et al. 1991. Self-assembled B19 parvovirus capsids, produced in a baculovirus system, are antigenically and immunogenically similar to native virions. Proc. Natl. Acad. Sci. USA 88:4646-50
4. Cohen BJ, Buckley MM. 1988. The prevalence of antibody to human parvovirus B19 in England and Wales. J. Med. Microbiol. 25:151-53
5. Koch WC, Adler SP. 1989. Human parvovirus B19 infections in women of childbearing age and within families. Pediatr. Infect. Dis. J. 8:83-87
6. Anderson MJ, Higgins PG, Davis LR, et al. 1985. Experimental parvoviral infection in humans. J. Infect. Dis. 152:257-65
7. Cohen BJ, Field AM, Gudnadottir S, et al. 1990. Blood donor screening for parvovirus B19. J. Virol. Methods 30:233-38
8. Williams MD, Cohen BJ, Beddall AC, et al. 1990. Transmission of human parvovirus B19 by coagulation factor concentrates. Vox Sang. 58:177-81
9. Woolf AD, Campion GV, Chishick A, et al. 1989. Clinical manifestations of human parvovirus B19 in adults. Arch. Intern. Med. 149:1153-56
10. White DG, Woolf AD, Mortimer PP, et al. 1985. Human parvovirus arthropathy. Lancet 1:419-21
11. Young N. 1988. Hematologic and hematopoietic consequences of B19 parvovirus infection. Semin. Hematol. 25:159-72
12. Shirono K, Tsuda H. 1995. Parvovirus B19-associated haemophagocytic syndrome in healthy adults. Br. J. Haematol. 89:923-26
13. Kurtzman GJ, Ozawa K, Cohen B, et al. 1987. Chronic bone marrow failure due to persistent B19 parvovirus infection. N. Engl. J. Med. 317:287-94
14. Frickhofen N, Abkowitz JL, Safford M, et al. 1990. Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS. Ann. Intern. Med. 113:926-33
15. Kurtzman GJ, Cohen B, Meyers P, et al. 1988. Persistent B19 parvovirus infection as a cause of severe chronic anaemia in children with acute lymphocytic leukaemia. Lancet 2:1159-62
16. Kurtzman G, Frickhofen N, Kimball J, et al. 1989. Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy. N. Engl. J. Med. 321:519-23
17. Public Health Laboratory Service Working Party on Fifth Disease. 1990. Prospective study of human parvovirus (B19) infection in pregnancy. Br. Med. J. 300:1166-70
18. Yaegashi N, Okamura K, Yajima A, et al. 1994. The frequency of human parvovirus B19 infection in nonimmune hydrops fetalis. J. Perinat. Med. 22:159-63
19. Brown KE, Green SW, Antunez de Mayolo J, et al. 1994. Congenital anaemia after transplacental B19 parvovirus infection. Lancet 343:895-96
20. Finkel TH, Torok TJ, Ferguson PJ, et al. 1994. Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiological agent? Lancet 343:1255-58
21. Brown KE, Young NS, Liu JM. 1994. Molecular, cellular and clinical aspects of parvovirus B19 infection. Crit. Rev. Oncol. Hematol. 16:1-31
22. Anderson MJ, Jones SE, Minson AC. 1985. Diagnosis of human parvovirus infection by dot-blot hybridization using cloned viral DNA. J. Med. Virol. 15:163-72
23. Cohen BJ, Mortimer PP, Pereira MS. 1983. Diagnostic assays with monoclonal antibodies for the human serum parvovirus-like virus (SPLV). J. Hyg. 91:113-30
24. Patou G, Pillay D, Myint S, Pattison J. 1993. Characterization of a nested polymerase chain reaction assay for detection of parvovirus B19. J. Clin. Microbiol. 31: 540-46
25. Mortimer PP, Humphries RK, Moore JG, et al. 1983. A human parvovirus-like virus inhibits haematopoietic colony formation in vitro. Nature 302:426-29
26. Morey AL, Ferguson DJ, Fleming KA. 1993. Ultrastructural features of fetal erythroid precursors infected with parvovirus B19 in vitro: evidence of cell death by apoptosis. J. Pathol. 169:213-20
27. Brown KE, Anderson SM, Young NS. 1993. Erythrocyte Pantigen: cellular receptor for B19 parvovirus. Science 262:114-17
28. Brown KE, Hibbs JR, Gallinella G, et al. 1994. Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen). N. Engl. J. Med. 330: 1192-96
29. Kurtzman GJ, Cohen BJ, Field AM, et al. 1989. Immune response to B19 parvovirus and an antibody defect in persistent viral infection. J. Clin. Invest. 84:1114-23
30. Connor E, Folena-Wasserman G, Alfonso C, et al. 1995. A phase 1 vaccine trial with recombinant parvovirus B19 virus-like particles in seronegative healthy adult volunteers. Blood 86(Suppl. 1):135a (Abstr.)